Compare Illumina, Inc. (ILMN) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Zillow Group Inc Class A — how do they compare? Illumina, Inc. trades at $189.99 (market cap $27.94B), while Zillow Group Inc Class A trades at $31.95 (market cap $7.54B). The key difference: Illumina, Inc. is far larger — about 3.7× Zillow Group Inc Class A's market cap, and Illumina, Inc. is trading nearer its 52-week high, Zillow Group Inc Class A nearer its low. Which is the better fit depends on your goals.
| ILMN | ZG | |
|---|---|---|
Market Cap | $27.94B | $7.54B |
Sector | Health | Media |
52-Week High | $194.33 | $86.76 |
52-Week Low | $91.00 | $29.14 |
Enterprise Value | $29.33B | $7.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
Zillow Group (ZG) trades at $32.84, down 2.58% on the day, amid a bearish technical signal and ongoing securities class action lawsuits. The company reported revenue of $2.58B in 2025 with a net income of $23M, marking a return to profitability after losses in prior years. Analyst consensus is a Buy with a $57.80 price target, but recent news highlights legal risks from alleged anticompetitive practices.
The outlook is mixed: strong fundamentals with improving margins and revenue growth support upside potential, but legal overhangs and bearish technicals pose near-term risks. Investors should weigh the high P/E ratio of 134.8 against earnings beats and analyst optimism for long-term recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
